In vivo and in vitro studies of Danzhi Jiangtang capsules against diabetic cardiomyopathy via TLR4/MyD88/NF-κB signaling pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In vivo and in vitro studies of Danzhi Jiangtang capsules against diabetic cardiomyopathy via TLR4/MyD88/NF-κB signaling pathway

Published:2021-12 Issue:12 Volume:29 Page:1432-1440
ISSN:1319-0164
Container-title:Saudi Pharmaceutical Journal
language:en
Short-container-title:Saudi Pharmaceutical Journal

Author:

Shi Hui,Zhou Peng,Ni Ying-qun,Wang Shu-shu,Song Rui,Shen An-lu,Fang Zhao-hui,Wang Liang

Funder

Natural Science Foundation of Anhui Province

Anhui University of Chinese Medicine

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmaceutical Science,Pharmacology

Reference34 articles.

1. The potential protective effects of diosmin on streptozotocin-induced diabetic cardiomyopathy in rats;Ali;Am. J. Med. Sci.,2020

2. Diabetic cardiomyopathy: Current and future therapies;Borghetti;Beyond glycemic control. Front Physiol.,2018

3. Effect of Danzhijiangtang capsule on monocyte chemoattractant protein-1 mRNA expression in newly diagnosed diabetes subclinical vascular lesions;Fang;World J. Gastroenterol.,2013

4. Protective effects of triptolide on TLR4 mediated autoimmune and inflammatory response induced myocardial fibrosis in diabetic cardiomyopathy;Guo;J. Ethnopharmacol.,2016

5. Necroptosis in microglia contributes to neuroinflammation and retinal degeneration through TLR4 activation;Huang;Cell Death Differ.,2018

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Programmed death of cardiomyocytes in cardiovascular disease and new therapeutic approaches;Pharmacological Research;2024-08

2. The signaling pathways of selected traditional Chinese medicine prescriptions and their metabolites in the treatment of diabetic cardiomyopathy: a review;Frontiers in Pharmacology;2024-07-03

3. NF-ĸB axis in diabetic neuropathy, cardiomyopathy and nephropathy: A roadmap from molecular intervention to therapeutic strategies;Heliyon;2024-05

4. The study of the mechanism of non-coding RNA regulation of programmed cell death in diabetic cardiomyopathy;Molecular and Cellular Biochemistry;2024-01-08

5. TAK-242 alleviates diabetic cardiomyopathy via inhibiting pyroptosis and TLR4/CaMKII/NLRP3 pathway;Open Life Sciences;2024-01-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3